Blog
RSS FeedPosted by Michael Wonder on 28 May 2018
ACCC loses appeal against Pfizer over Lipitor sales
25 May 2018 - A court has dismissed an Australian Competition and Consumer Commission appeal in a case in which ...
Posted by Michael Wonder on 28 May 2018
Community voices important to PHARMAC
28 May 2018 - This year, PHARMAC is reviewing the way we seek and incorporate the consumer voice in our ...
Posted by Michael Wonder on 27 May 2018
New drug to treat chronic lung disease has price slashed
27 May 2018 - More than half-a-million Australians with severe breathing difficulties from chronic lung disease will have the price ...
Posted by Michael Wonder on 27 May 2018
NICE issues decision on Mylotarg, Besponsa for leukaemia
25 May 2018 - NICE has issued draft guidelines backing restricted use of Pfizer’s Mylotarg for newly diagnosed acute myeloid ...
Posted by Michael Wonder on 27 May 2018
Medical bills: how out-of-pocket costs can get out of control
28 May 2018 - If you've seen a specialist in the private health sector, you'll likely know the pain of ...
Posted by Michael Wonder on 27 May 2018
'It's outrageous': Doctors slam practice of inflating patient fees
26 May 2018 - "Cowardly" specialists charging patients "egregious" out-of-pocket fees have been condemned by delegates at the Australian Medical ...
Posted by Michael Wonder on 26 May 2018
Flu vaccine stocks to be boosted after early rush saps supplies across Australia
26 May 2018 - An extra 800,000 doses of the flu vaccine will be manufactured in response to increasing shortages ...
Posted by Michael Wonder on 25 May 2018
Out of pocket costs undermining health system
25 May 2018 - Irrespective of whether or not ‘harvesting’ by public hospitals of privately insured patients is occurring, next ...
Posted by Michael Wonder on 25 May 2018
Flu vaccine to be reserved for most vulnerable as supplies dry up
25 May 2018 - Victoria’s stocks of the flu vaccine are almost exhausted and remaining supplies will be reserved for ...
Posted by Michael Wonder on 24 May 2018
New melanoma guidelines recommend $150,000 a year treatment that’s not subsidised
25 May 2018 - Sweeping changes to medical guidelines for melanoma could halve the rate at which the cancer recurs ...
Posted by Michael Wonder on 23 May 2018
Health report confirms: consumers want control of their own health data
23 May 2018 - Australians want ownership and control of their own health data and want to be asked for ...
Posted by Michael Wonder on 23 May 2018
NICE says no to Chiesi’s rare disease drug
23 May 2018 - England’s cost effectiveness watchdog NICE has published draft guidance not recommending Chiesi’s enzyme replacement therapy Lamzede ...
Posted by Michael Wonder on 23 May 2018
Rationing medicines by stealth with Government budget announcement
17 May 2018 - Big expectations from the Government today as it increases the pressure on PHARMAC to perform with ...
Posted by Michael Wonder on 22 May 2018
Holistic approach to palliative care required for consumers and carers
22 May 2018 - Palliative Care Australia, Consumers Health Forum of Australia and Carers Australia released the Consensus Statement: Carer ...
Posted by Michael Wonder on 22 May 2018
Okanagan MLA pushes province, drug company to provide compassionate coverage for pricey drug
22 May 2018 - It’s been more than four months since a Vernon woman with cystic fibrosis was forced to ...